Davida M Schiff
Biographic Data
| ID | 6084347 |
|---|---|
| NAME | Davida M Schiff |
| GIVEN NAMES | Davida M |
| FAMILY NAME | Schiff |
| SIGNATURE | SCHIFF D M |
| AFFILIATIONS | Massachusetts General Hospital |
| ORCID | 0000-0002-6435-1016 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Variation in Perinatal Toxicology Testing and Consent Practices Among United States Birthing Hospitals
Addressing Children and Families within the National Drug Control Strategy
In recognition of the potentially devastating effects on family well-being related to opioids and caregiver substance use in the United-States including increasing rates of overdose among individuals of reproductive age, opioid-related pediatric fatalities, and family disruptions, this commentary provides an expanded approach for policy frameworks to meaningfully integrate children, parents, and families. Building from the White House's 2022 Nati…
Development of a Clinical Decision-Making Framework to Address Parental Substance Use and Child Safety
Five main assessment areas will be discussed, including: 1). Safety of the child while substance use is occurring; 2). Safety of parental use patterns; 3). Parental treatment engagement; 4). Willingness to escalate treatment services; and 5). Stability of the home environment. We will present a clinical scenario to highlight how the framework is used as an aid to determine action planning with respect to immediate safety concerns, treatment escal…
Expansion and commentary on a two generation approach to prenatal opioid exposure – a commentary on Conradt et al. (2023)
Early child neurodevelopment, including psychopathology, is influenced by a myriad of factors and interactions. These factors are both intrinsic to the caregiver–child dyad such as genetics and epigenetics as well as extrinsic such as social environment and enrichment. Additional layers of complexity may be at play within families with parental substance use, as outlined by Conradt et al. (2023) in their review article titled “Prenatal Opioid Exp…
Prescribed and Penalized
Uncoupling of OUD treatment decisions in the perinatal period from mandated CPS reporting at time of delivery is essential. The primary focus for families affected by OUD must shift from surveillance and stigma to evidence-based treatment and access to supportive services and resources
Lessons Learned Serving Pregnant, Postpartum, and Parenting People with Substance Use Disorders in Massachusetts
MDC prioritizes trauma-informed integrated care, peer recovery, and commits to addressing inequities and stigma; thus, this program represents a promising approach to supporting PPPP impacted by SUD. The MDC model is relevant for those working to build multidisciplinary, integrated systems of health care and perinatal SUD services for marginalized populations
Risk of Severe Maternal Morbidity in Birthing People With Opioid Use Disorder
Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother–Infant Dyads in Massachusetts (2017–2019)
Objectives. To examine the extent to which differences in medication for opioid use disorder (MOUD) in pregnancy and infant neonatal opioid withdrawal syndrome (NOWS) outcomes are associated with maternal race/ethnicity. Methods. We performed a secondary analysis of a statewide quality improvement database of opioid-exposed deliveries from January 2017 to April 2019 from 24 hospitals in Massachusetts. We used multivariable mixed-effects logistic …
Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother–Infant Dyads in Massachusetts (2017–2019)
Objectives. To examine the extent to which differences in medication for opioid use disorder (MOUD) in pregnancy and infant neonatal opioid withdrawal syndrome (NOWS) outcomes are associated with maternal race/ethnicity. Methods. We performed a secondary analysis of a statewide quality improvement database of opioid-exposed deliveries from January 2017 to April 2019 from 24 hospitals in Massachusetts. We used multivariable mixed-effects logistic …
Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother–Infant Dyads in Massachusetts (2017–2019)
Objectives. To examine the extent to which differences in medication for opioid use disorder (MOUD) in pregnancy and infant neonatal opioid withdrawal syndrome (NOWS) outcomes are associated with maternal race/ethnicity. Methods. We performed a secondary analysis of a statewide quality improvement database of opioid-exposed deliveries from January 2017 to April 2019 from 24 hospitals in Massachusetts. We used multivariable mixed-effects logistic …
Expansion and commentary on a two generation approach to prenatal opioid exposure – a commentary on Conradt et al. (2023)
Early child neurodevelopment, including psychopathology, is influenced by a myriad of factors and interactions. These factors are both intrinsic to the caregiver–child dyad such as genetics and epigenetics as well as extrinsic such as social environment and enrichment. Additional layers of complexity may be at play within families with parental substance use, as outlined by Conradt et al. (2023) in their review article titled “Prenatal Opioid Exp…
Prescribed and Penalized
Uncoupling of OUD treatment decisions in the perinatal period from mandated CPS reporting at time of delivery is essential. The primary focus for families affected by OUD must shift from surveillance and stigma to evidence-based treatment and access to supportive services and resources
Lessons Learned Serving Pregnant, Postpartum, and Parenting People with Substance Use Disorders in Massachusetts
MDC prioritizes trauma-informed integrated care, peer recovery, and commits to addressing inequities and stigma; thus, this program represents a promising approach to supporting PPPP impacted by SUD. The MDC model is relevant for those working to build multidisciplinary, integrated systems of health care and perinatal SUD services for marginalized populations
Risk of Severe Maternal Morbidity in Birthing People With Opioid Use Disorder
Addressing Children and Families within the National Drug Control Strategy
In recognition of the potentially devastating effects on family well-being related to opioids and caregiver substance use in the United-States including increasing rates of overdose among individuals of reproductive age, opioid-related pediatric fatalities, and family disruptions, this commentary provides an expanded approach for policy frameworks to meaningfully integrate children, parents, and families. Building from the White House's 2022 Nati…
Development of a Clinical Decision-Making Framework to Address Parental Substance Use and Child Safety
Five main assessment areas will be discussed, including: 1). Safety of the child while substance use is occurring; 2). Safety of parental use patterns; 3). Parental treatment engagement; 4). Willingness to escalate treatment services; and 5). Stability of the home environment. We will present a clinical scenario to highlight how the framework is used as an aid to determine action planning with respect to immediate safety concerns, treatment escal…
Variation in Perinatal Toxicology Testing and Consent Practices Among United States Birthing Hospitals
Prenatal Substance Exposure Effects (8 works) · Maternal Mental Health During Pregnancy and Postpartum (6 works) · Medicine (5 works) · Psychiatry (5 works) · Opioid (4 works) · Opioid use disorder (4 works) · Pregnancy (4 works) · Homelessness and Social Issues (3 works) · Psychology (3 works) · Confidence interval (2 works)